2002•PubMedRequires access

[Association between early-onset coronary heart disease and angiotensin II type 1 receptor gene polymorphism].

Jian Peng, Shu Peng, Wu-xing Gong

Open publisher page 6 citations

Abstract

OBJECTIVE: To study the association between early-onset coronary heart disease (CHD) and angiotensin II type 1 receptor (ATIR) gene A1166/C polymorphism and the effect of ATIR gene A1166/C on the plasma lipid level. METHODS: The ATIR A1166/C genotype of 71 early-onset CHD patients, 76 late-onset CHD patients, and 119 controls was examined by PCR-RFLP. Their plasma lipid levels were detected. RESULTS: Two ATIR genotypes, AC and AA, were detected. The frequencies (97.2% vs 92.1% vs 94.1%) of genotypes AA and AC and the frequencies of allele A and allele C in the three groups were similar. No difference were found among the levels of plasma lipids in the group of early-onset CHD patients with AA (94.1% vs 5.9%) or AC genotypes (2.8% vs 7.9%). CONCLUSION: There is no association between between ATIR gene A1166/C polymorphism and occurrence of early-onset CHD. ATIR geng A1166/C polymorphism has no effect on plasma lipid levels.

About this research paper

What this paper is about

OBJECTIVE: To study the association between early-onset coronary heart disease (CHD) and angiotensin II type 1 receptor (ATIR) gene A1166/C polymorphism and the effect of ATIR gene A1166/C on the plasma lipid level. METHODS: The ATIR A1166/C genotype of 71 early-onset CHD patients, 76 late-onset CHD patients, and 119 controls was examined by PCR-RFLP. Their plasma lipid levels were detected. RESULTS: Two ATIR genotypes, AC and AA, were detected. The frequencies (97.2% vs 92.1% vs 94.1%) of genotypes AA and AC and the frequencies of allele A and allele C in the three groups were similar. No difference were found among the levels of plasma lipids in the group of early-onset CHD patients with AA (94.1% vs 5.9%) or AC genotypes (2.8% vs 7.9%). CONCLUSION: There is no association between between ATIR gene A1166/C polymorphism and occurrence of early-onset CHD. ATIR geng A1166/C polymorphism has no effect on plasma lipid levels.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the association between early-onset coronary heart disease (CHD) and angiotensin II type 1 receptor (ATIR) gene A1166/C polymorphism and the effect of ATIR gene A1166/C on the plasma lipid level. METHODS: The ATIR A1166/C genotype of 71 early-onset CHD patients, 76 late-onset CHD patients, and 119 controls was examined by PCR-RFLP. Their plasma lipid levels were detected. RESULTS: Two ATIR genotypes, AC and AA, were detected. The frequencies (97.2% vs 92.1% vs 94.1%) of genotypes AA and AC and the frequencies of allele A and allele C in the three groups were similar. No difference were found among the levels of plasma lipids in the group of early-onset CHD patients with AA (94.1% vs 5.9%) or AC genotypes (2.8% vs 7.9%). CONCLUSION: There is no association between between ATIR gene A1166/C polymorphism and occurrence of early-onset CHD. ATIR geng A1166/C polymorphism has no effect on plasma lipid levels.

Key concepts: Genotype, Internal medicine, Allele, Endocrinology, Allele frequency, Polymorphism (computer science), Gene polymorphism, Coronary heart disease

Related papers

Back to paper searchBrowse research topicsOriginal source
[Association between early-onset coronary heart disease and angiotensin II type 1 receptor gene polymorphism]. — Research Paper | ScholarLens